Delayed clearance of triglyceride-rich lipoproteins in young, healthy obese subjects

Clinical Obesity

Volumn 5, Issue 6, 2015, Pages 349-357

  Larsen, M A ^a   Goll, R ^a,b   Lekahl, S ^c   Moen, O S ^a   Florholmen, J ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c Helse Sør Øst   (Norway)

Author keywords

Chylomicrons; Fasting triglycerides; Insulin resistance; Metabolic healthy obese

Indexed keywords

APOLIPOPROTEIN; CHYLOMICRON; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT TOLERANCE TEST; FEMALE; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; IMMUNOCHEMISTRY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG ADULT;

EID: 85047103205     PISSN: 17588103     EISSN: 17588111     Source Type: Journal    
DOI: 10.1111/cob.12118     Document Type: Article

References (38)

1. Lim SS, Vos T, Flaxman AD etal. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260.
2. James WP. A public health approach to the problem of obesity. Int J Obes Relat Metab Disord 1995; 19(Suppl. 3): S37-S45.
3. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? BMJ 1995; 311: 437-439.
4. Tonstad S, Despres JP. Treatment of lipid disorders in obesity. Expert Rev Cardiovasc Ther 2011; 9: 1069-1080.
5. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-485.
6. Proctor SD, Mamo JC. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron Artery Dis 1996; 7: 239-245.
7. Proctor SD, Vine DF, Mamo JC. Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler Thromb Vasc Biol 2004; 24: 2162-2167.
8. Patsch JR, Miesenbock G, Hopferwieser T etal. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-1345.
9. Weintraub MS, Grosskopf I, Rassin T etal. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 1996; 312: 935-939.
10. Ooi TC, Cousins M, Ooi DS etal. Postprandial remnant-like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab 2001; 86: 3134-3142.
11. Olivecrona T, Olivecrona G. Lipoprotein Lipase and Hepatic Lipase in Lipoprotein Metabolism. Arnold: London, 1999.
12. Panarotto D, Rémillard P, Bouffard L, Maheux P. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest 2002; 32: 84-92.
13. Emmons RR, Garber CE, Cirnigliaro CM etal. The influence of visceral fat on the postprandial lipemic response in men with paraplegia. J Am Coll Nutr 2010; 29: 476-481.
14. Blackburn P, Lamarche B, Couillard C etal. Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance. Diabetes Care 2003; 26: 3303-3309.
15. Mekki N, Christofilis MA, Charbonnier M etal. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J Clin Endocrinol Metab 1999; 84: 184-191.
16. Vansant G, Mertens A, Muls E. Determinants of postprandial lipemia in obese women. Int J Obes Relat Metab Disord 1999; 23(Suppl. 1): 14-21.
17. Guerci B, Verges B, Durlach V etal. Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients. Int J Obes Relat Metab Disord 2000; 24: 468-478.
18. Nabeno-Kaeriyama Y, Fukuchi Y, Hayashi S etal. Delayed postprandial metabolism of triglyceride-rich lipoproteins in obese young men compared to lean young men. Clin Chim Acta 2010; 411: 1694-1699.
19. Cohen JC. Chylomicron triglyceride clearance: comparison of three assessment methods. Am J Clin Nutr 1989; 49: 306-313.
20. Nordoy A, Bønaa KH, Sandset PM, Hansen JB, Nilsen H. Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia. Nutr Metab Cardiovasc Dis 2000; 10: 15-23.
21. Lekhal S, Borvik T, Nordoy A, Hansen JB. Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction. Lipids 2008; 43: 507-515.
22. Aviram M, Brox J, Nordoy A. Effects of postprandial plasma and chylomicrons on endothelial cells. Differences between dietary cream and cod liver oil. Acta Med Scand 1986; 219: 341-348.
23. Terpstra AH. Isolation of serum chylomicrons prior to density gradient ultracentrifugation of other serum lipoprotein classes. Anal Biochem 1985; 150: 221-227.
24. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583-595.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
26. Matthews DR, Hosker JP, Rudenski AS etal. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
27. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
28. Esteghamati A, Ashraf H, Khalilzadeh O etal. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond) 2010; 7: 26.
29. Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX etal. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 2013; 13: 47.
30. Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX etal. Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Res Clin Pract 2011; 94: 146-155.
31. Wedin WK, Diaz-Gimenez L, Convit AJ. Prediction of insulin resistance with anthropometric measures: lessons from a large adolescent population. Diabetes Metab Syndr Obes 2012; 5: 219-225.
32. Duez H, Lamarche B, Uffelman KD etal. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol 2006; 26: 1357-1363.
33. Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 2007; 98: 458-473.
34. Nakajima K, Nakano T, Moon HD etal. The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers. Clin Chim Acta 2009; 404: 124-127.
35. Kolovou GD, Mikhailidis DP, Kovar J etal. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 2011; 9: 258-270.
36. Rashid S, Uffelman KD, Lewis GF. The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states. J Diabetes Complications 2002; 16: 24-28.
37. Agledahl I, Hansen JB, Svartberg J. Postprandial triglyceride metabolism in elderly men with subnormal testosterone levels. Asian J Androl 2008; 10: 542-549.
38. Alcala-Diaz JF, Delgado-Lista J, Perez-Martinez P etal. Hypertriglyceridemia influences the degree of postprandial lipemic response in patients with metabolic syndrome and coronary artery disease: from the CORDIOPREV study. PLoS ONE 2014; 9: e96297.